Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110023/S069

EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste

Medtronic Vascular, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP110023/S069

What did the FDA decide?

The FDA record shows an OK30 decision dated 2026-10-16 for P110023/S069, filed by Medtronic Vascular, Inc. as a 30-Day Notice. The listed reason is a process change involving a manufacturer, sterilizer, packager or supplier. The supplied statement describes the scope as a sterilization monitoring change: reducing the incubation time for the biological indicator used in external process challenge devices. The product area is a superficial femoral artery stent under product code NIP.

The identifier links the notice to PMA P110023, but a supplement is not an approval of the whole stent system, and a manufacturing notice is not an original PMA. The reported purpose concerns sterilization monitoring, not new clinical evidence; the record does not show the new incubation time, the indicator or device manufacturer, validation results, or whether the FDA reviewed supporting data. The source does not establish safety or effectiveness for any clinical use.

FDA approval order statement

approval for a sterilization monitoring change to reduce incubation time for the biological indicator used in external process challenge devices
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P110023/S069
Regulatory pathway
PMA supplement
Product code
NIP
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

For the original device and its historical approval scope, see PMA P110023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P110023 · Original PMA

    EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

  2. P110023/S069 received

    Application receipt date recorded by FDA.

  3. P110023/S069 · FDA decision

    30-Day Notice

  4. P110023/S070 · Related supplement

    EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

Timeline entries are records held by MedtechLedger for P110023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110023

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalMar 7, 2012FDA
Medtronic Vascular, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records